Tiny trial tests Dual-Radiation attack on returning prostate cancer
Disease control
Completed
This early study tested whether adding a radioactive drug (177Lu-PSMA) to standard brachytherapy is safe and feasible for men whose prostate cancer returned after initial radiation. Only 3 men took part. The goal was to see if the combination could control cancer both in the pros…
Phase: PHASE1, PHASE2 • Sponsor: Glenn Bauman • Aim: Disease control
Last updated Jun 26, 2026 16:03 UTC